NCT05640037View on ClinicalTrials.gov

Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis

CompletedOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

March 23, 2022

Primary Completion Date

March 20, 2024

Study Completion Date

March 20, 2024

Conditions
Sepsis
Trial Locations (1)

Unknown

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER